Diego Miralles, M.D.

Board Member

Equibles does not estimate personal net worth.

Get an email with a short summary when Contineum Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.

Get CTNM alerts

About Diego Miralles, M.D.

Diego Miralles, M.D. is recorded as Board Member at Contineum Therapeutics, Inc. (CTNM) since March 14, 2025. Contineum Therapeutics, Inc. reported in an 8-K filed March 17, 2025 that Diego Miralles, M.D. was appointed member of its Board, effective March 14, 2025. Contineum Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Contineum Therapeutics, Inc. includes Carmine N. Stengone (CEO and Board Member), Peter T. Slover (CFO), John S. Healy (General Counsel) and 6 others.

“On March 14, 2025, the board of directors (the "Board") of Contineum Therapeutics, Inc. (the "Company") appointed Diego Miralles, M.D. as a member of its Board, effective March 14, 2025.”

Contineum Therapeutics, Inc. Form 8-K, filed March 17, 2025 · Read the filing

Affiliation history

Contineum Therapeutics, Inc. (CTNM)
Board Member

SEC 8-K

Current
2025-03-14–present

Company network

Contineum Therapeutics, Inc.

CTNM

Current role

Biotechnology · Healthcare

Board Member

2025-03-14–present

Leadership on record at Contineum Therapeutics, Inc.

Carmine N. Stengone CEO, Board Member
Peter T. Slover CFO
John S. Healy General Counsel
Diego Miralles Board Member
Lori M. Lyons-Williams Board Member
Olivia Ware Board Member
Sarah Boyce Board Member
Todd Brady Board Member
Troy Ignelzi Board Member

Recent activity

Executive change Appointed: member of its Board Contineum Therapeutics, Inc. (CTNM)
2025-03-14